Search results
Citigroup Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 3 days agoCitigroup Inc (NYSE:C) recently announced a dividend of $0.53 per share, payable on 2024-05-24, with the ex-dividend date set for 2024-05-03. As...
Victory Capital Management Inc. Acquires 662,428 Shares of Citigroup Inc. (NYSE:C)
ETF DAILY NEWS· 1 day agoVictory Capital Management Inc. raised its holdings in shares of Citigroup Inc. (NYSE:C – Free Report) by 65.0% in the 4th quarter, according to its most recent Form 13F filing ...
Exclusive-Citigroup sees loan book hit in climate action ramp-up, document shows
Reuters via Yahoo Finance· 4 days agoNEW YORK/WASHINGTON (Reuters) -Citigroup could suffer billions of dollars of losses in its loan book...
Citigroup Lowers Northern Oil and Gas (NYSE:NOG) Price Target to $50.00
ETF DAILY NEWS· 10 hours agoCitigroup’s price objective suggests a potential upside of 24.22% from the stock’s previous close. Royal Bank of Canada reissued an “outperform” rating and set a $46.00 price ...
Citigroup Sees Unusually High Options Volume (NYSE:C)
ETF DAILY NEWS· 2 days agoCitigroup Inc. (NYSE:C – Get Free Report) was the recipient of unusually large options trading activity on Thursday. The company has a market capitalization of $117.79 billion ...
Citigroup Inc. (C) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 3 days agoCitigroup (C) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
Blueprint Medicines (NASDAQ:BPMC) Given New $76.00 Price Target at Citigroup
ETF DAILY NEWS· 10 hours agoBlueprint Medicines (NASDAQ:BPMC – Get Free Report) had its target price increased by equities researchers at Citigroup from $65.00 to $76.00 in a research note issued to ...
Neurocrine Biosciences (NASDAQ:NBIX) PT Raised to $150.00 at Citigroup
ETF DAILY NEWS· 10 hours agoNeurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lifted by equities research analysts at Citigroup from $140.00 to $150.00 in a research report ...
Citigroup (NYSE:C) Price Target Lowered to $86.00 at Oppenheimer
ETF DAILY NEWS· 5 days agoCitigroup (NYSE:C – Free Report) had its price target decreased by Oppenheimer from $87.00 to $86.00 in a report published on Tuesday, Benzinga reports. Oppenheimer currently ...
Citigroup outfits Tampa campus with large solar array - Tampa Bay Business Journal
The Business Journals· 2 days agoCitigroup Inc. will power a portion of its Tampa campus with a new rooftop solar project. The bank...